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genetic processes. Functional studies in primary human chondrocytes
have long been hampered by the low transfection efﬁciencies of non-viral
gene delivery methods in these cells. Only with the development of spe-
ciﬁc electroporation methods like nucleofection and radiofrequency (RF)
electroporation highly efﬁcient non-viral transfection protocols for human
chondrocytes became available, but these methods require relatively high
cell numbers and cannot be easily adjusted to the analysis of a larger
number of samples. The purpose of our work was therefore the estab-
lishment of a high-throughput transfection protocol for primary human
articular chondrocytes (PHC) that allows the simultaneous transfection of
multiple cell samples while reducing the number of cells necessary per
experiment. In parallel analogous protocols should be established for the
human chondrocytic cell lines T/C-28a2 and HCS-2/8.
Methods: Primary human chondrocytes were isolated from adult knee
cartilage by an optimized enzymatic digestion protocol and cultivated in
high-density monolayer culture for three to ﬁve days. T/C-28a2 and HCS-
2/8 cells were cultivated under standard conditions. Chondrocytes and
chondrocytic cell lines were transfected with an GFP expressing reporter
construct applying amaxa’s nucleofector and 96-well shuttle devices with
experimental variation of transfection parameters, pulse solutions and
cell numbers. Transfection efﬁciencies were measured by FACS and cell
viability was determined by an ATP assay. SiRNA constructs targeting
GAPDH expression were transfected into the cells using the established
nucleofection protocols and mRNA knockdown values were determined
by a branched-DNA assay or by quantitative real-time PCR.
Results: For high-throughput transfection of primary human chondro-
cytes transfection efﬁciencies of more than 70% of surviving cells could be
achieved routinely with the presented nucleofection protocol. Cell viability
after transfection was around 80%. Transfection efﬁciency and survival
rate were highly dependent on the proper preparation of the PHCs prior
to transfection. The cell number used for transfection could be reduced
to 2×105 per sample in comparison to the established single cuvette
protocol. The protocol proved also well suited for the transfer of siRNA
molecules to primary human chondrocytes with suppression rates of more
than 95% for GAPDH mRNA levels. Transfection efﬁciencies for T/C-28a2
cells surpassed 90% for both single cuvette and high-throughput formats
with survival rates of more than 80%. Single cuvette nucleofection of
HCS-2/8 cells reached transfection efﬁciencies of around 40%.
Conclusions: We present the successful adaptation of the nucleofection
procedure for primary human chondrocytes to a high-throughput format.
The protocol allows the efﬁcient transfection of up to 96 cell samples in
parallel and is not limited to the transfection of DNA but can be easily
adapted to the transfection of siRNA constructs. The protocol requires
substantially lower cell numbers than single cuvette protocols and is
therefore very well suited for applications requiring multiple experimental
replicates. Likewise, the established protocols for T/C-28a2 cells allow the
highly efﬁcient transfection in single cuvette and 96-well formats opening
novel application areas. In summary, we present efﬁcient high-throughput
transfection protocols for primary human chondrocytes and chondrocyte-
derived cell lines with widespread application potential in osteoarthritis
research (siRNA screening assays etc.).
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Purpose: Population of mesenchymal stem cells (MSC) is formed by
subsets which have different capacity of cellular differentiation. This study
compares the capacity to repair in vitro chondral defect between the
subset of MSC CD271+ and the subset MSC CD271-.
Methods:MSC were isolated from bone marrow samples of osteoarthritic
patients (n = 4; mean age: 64 years). These cells were characterized by
ﬂow cytometry for hematopoietic (CD34 and CD45) and mesenchymal
(CD44, CD73, CD90, CD105, CD117 and CD166) markers, and its
differentiation potential (adipogenesis, osteogenesis and chondrogene-
sis) was determined. The MSC were magnetically separated (MACS®
Separation Columns LS, Miltenyi) in two groups: CD271+ and CD271-.
In focal defects of articular cartilage (2mm of diameter) MSC CD271+
or MSC CD271− were deposited. The implants were cultured in chon-
drogenic differentiation medium supplemented with recombinant human
transforming growth factor-beta3 (rHuTGF-beta3) during 8 weeks. The
repair tissues were analyzed by histochemical (hematoxilin-eosin and
safranin O) and immunohistochemical (types I and II collagens) methods.
A semiquantitative histologic scoring system was used to evaluated the
repair tissue. The repair percentage was calculated by the formula: (area
of neo-synthesized tissue/Area of the original chondral defect) ×100.
Results: MSC resulted negative for CD34 and CD45, positive for CD44,
CD73, CD90, CD105 and CD166. Furthermore, they showed capacity for
chondrogenic, osteogenic and adipogenic differentiation. In both groups
of implants, the repair tissue showed morphology like articular cartilage
(extracellular matrix with a hyaline aspect and numerous lacunae contain-
ing cells of rounded shape), a cellular density higher in repair tissue than
in the native cartilage and the expression of types I and II collagens.
However, both groups showed differences: the ﬁlling of the chondral
defect with repair tissue was lower in the implants with MSC CD271−
(32.2±9.7%) than in those with MSC CD271+ (59.9±16.6%); safranin O
stain of the repair tissue was negative in the implants with CMM CD271−
and moderate positive in implants with MSC CD271+; and the integration
between the repair tissue and the adjacent normal cartilage resulted of
higher quality in the MSC CD271+ implants. Total score was 9.5±0.89
and 12.19±1.01 for implants CD271− and implants CD271+ respectively.
Conclusions: Our results indicate that the subset MSC CD271+ brings
a chondral repair of higher quality than the subset CD271−.
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Purpose: Mesenchymal stem cells (MSC) from OA and normal patient
synovial membranes have been differentiated towards chondrocyte-like
cells which would be a good source to transplant articular cartilage.
AIM: To analyze whether spheroid methodology is useful to study the
chondrogenesis process. To compare the chondrogenesis process using
CD-105+ MSC from OA and normal synovium.
Methods: Synovial membrane from osteoarthritic cartilage was obtained
from patients undergoing total knee arthroplasty. Normal synovial mem-
brane from articular cartilage was obtained from donors who had no
history of joint disease. Tissues were digested in a cocktail of colla-
gen/dispase. MSC were seeded in plates and preplating was done to
get of rid of ﬁbroblasts. Subpopulation CD-105+ was separated using
a magnetic separator (MACS® Separation Colums LS, Miltenyi) and
they were differentiated towards chondrocyte-like cells using a medium
with FBS to promote spheroid formation. After two days medium was
changed by a chondrogenic medium which was changed every four
days. Spheroids were colleted after 14, 24 and 46 days in chondrogenic
medium. Spheroids were stained with hematoxylin, eosin and Safranin
O or blue alcian to evaluate the distribution of matrix, proteoglycan
and aggrecan. Immunohistochemestry studies were carried out to study
COL1, COL2 and MMP-13.
Results: Spheroid appears after 7 days in chondrogenic medium. Studies
showed no differences between MSC from OA and normal synovial
membrane in the chondrogenesis procedure. Intensity of Safranin O was
higher at 24 days than at 46 days in culture. It was found the highest
intensity in the expression of COL2 after 28 days in culture (100%);
meanwhile the expression is lower at 14 and 46 days in culture (60%).
COL1 (20−30%) is less intense than COL2 at three times studied, we
found the highest expression of COL1 (30%) at 14 days in culture. MMP-
13 has its maximum level of intensity (100%) at 46 days in culture.
Conclusions: Differentiate chondrocyte-like cells from MSC synovial
membrane through spheroid formation is a useful method to study chon-
drogenesis. No differences between OA and Normal MSC were found in
the chondrogenesis process.
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